We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Questionnaire and Laboratory Data on Vitiligo Vulgaris

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01206374
Recruitment Status : Completed
First Posted : September 21, 2010
Last Update Posted : May 25, 2015
Information provided by (Responsible Party):

September 20, 2010
September 21, 2010
May 25, 2015
August 2010
October 2010   (Final data collection date for primary outcome measure)
Quality of life disturbances in people with vitiligo [ Time Frame: point prevalence ]
dermatology life quality indices were you used and correlated with location of disease
Not Provided
Complete list of historical versions of study NCT01206374 on ClinicalTrials.gov Archive Site
self-reporting of vitiligo disease symptoms and history [ Time Frame: single survey ]
Correlation of the patient survey response with chart documentation was performed.
Not Provided
Not Provided
Not Provided
Questionnaire and Laboratory Data on Vitiligo Vulgaris
Demographic and Laboratory Data Collection for Patients With Vitiligo Vulgaris
Vitiligo vulgaris is an autoimmune disorder that causes loss of pigmentation over the skin, hair and mucous membranes (e.g. lips, nose, genitals). While genes have been identified that are thought to be required for development of vitiligo, only 5-10% of relatives develop disease. The triggers for disease onset have not yet been identified. The intent of this study is to research trends in laboratory data, social and medical history that may be contributory to vitiligo onset, location of disease, course of illness and response to therapy.
Patients who participate in this study will be asked to complete a survey and have blood/ laboratory testing performed that relates or may relate to the diagnosis of vitiligo.
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample
All patients willing to sign consent, complete questionnaire and/ or laboratory studies.
Vitiligo Vulgaris
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
September 2014
October 2010   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Diagnosis of Vitiligo Vulgaris
  • Ability to sign consent

Exclusion Criteria:

  • Pregnant
  • Inability to sign consent
  • Inability to complete questionnaire
Sexes Eligible for Study: All
Child, Adult, Senior
Contact information is only displayed when the study is recruiting subjects
United States
Not Provided
Not Provided
St. Luke's-Roosevelt Hospital Center
St. Luke's-Roosevelt Hospital Center
Beth Israel Medical Center
Principal Investigator: Nanette Silverberg, MD StLukesNY
St. Luke's-Roosevelt Hospital Center
May 2015